# Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso

> **NCT00845533** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco**

## Conditions studied

- Uncomplicated Malaria

## Interventions

- **DRUG:** Dihydroartemisinin-Piperaquine

## Key facts

- **NCT ID:** NCT00845533
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2007-12
- **Final completion:** 2009-01
- **Target enrollment:** — (—)
- **Last updated:** 2014-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845533, "Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00845533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
